Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 2, 2003, Pages 328-334

  Kleinberg, Lawrence ^a   Knisely, Jonathan P S ^b   Heitmiller, Richard ^a   Zahurak, Marriana ^a   Salem, Ronald ^b   Burtness, Barbara ^b   Heath, Elizabeth I ^a   Forastiere, Arlene A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

Esophageal cancer; Neoadjuvant therapy; Survival

Indexed keywords

CHEMOTHERAPY; PATHOLOGY; SURGERY; TUMORS;

CHEMORADIOTHERAPY;

RADIOTHERAPY;

ANALGESIC AGENT; ANTACID AGENT; ANTIEMETIC AGENT; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DEATH; DIARRHEA; DOSE RESPONSE; ESOPHAGITIS; ESOPHAGUS; ESOPHAGUS CANCER; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PATHOLOGY; PERIPHERAL NEUROPATHY; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR LOCALIZATION; VOMITING;

EID: 0038301114     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04598-4     Document Type: Article

References (18)

1. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:1996;462-467.
2. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 19:2001;305-313.
3. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 337:1997;161-167.
4. Leichman LP. Role and context of definitive nonoperative therapy for esophageal cancer. In: Perry MC, editor. American Society of Clinical Oncology Education Book. Alexandria, VA: American Society of Clinical Oncology; 2000. p. 516-521.
5. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 339:1998;1979-1984.
6. Forastiere A.A., Heitmiller R.F., Lee D.J., et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 3:1997;144-152.
7. Heath E.I., Burtness B.A., Heitmiller R.F., et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol. 18:2000;868-876.
8. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 53:1958;457-480.
9. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748.
10. Cox D.R. Regression models and life-tables (with discussion). J Roy Statist Soc (B). 34:1972;187-220.
11. SAS user's guide. Statistics, version 5. 1985;SAS Institute, Cary, NC.
12. EGRET users' manual. 1988;SERC, Seattle.
13. Ellis F.H. Jr. Standard resection for cancer of the esophagus and cardia. Surg Oncol Clin North Am. 8:1999;279-294.
14. Forastiere A.A., Orringer M.B., Perez-Tamayo C., et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus Final report . J Clin Oncol. 11:1993;1118-1123.
15. Bedenne L., Seitz J.F., Milan C., et al. Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer Multicenter phase II FFCD 8804 study . Gastroenterol Clin Biol. 22:1998;273-281.
16. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer Long-term follow-up of a prospective randomized trial (RTOG 85-01) . JAMA. 281:1999;1623-1627.
17. Smith T.J., Ryan L.M., Douglas H.O. Jr, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus A study of the Eastern Cooperative Oncology Group . Int J Radiat Oncol Biol Phys. 42:1998;269-276.
18. Geh J.I., Crellin A.m, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg. 88:2001;338-356.